Latest Nan Fung Group Holdings Ltd Stock Portfolio
Nan Fung Group Holdings Ltd Performance:
2024 Q3: 8.62%YTD: 7.55%2023: -10.57%
Performance for 2024 Q3 is 8.62%, and YTD is 7.55%, and 2023 is -10.57%.
About Nan Fung Group Holdings Ltd and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Nan Fung Group Holdings Ltd reported an equity portfolio of $116.1 Millions as of 30 Sep, 2024.
The top stock holdings of Nan Fung Group Holdings Ltd are ILMN, HRMY, GERN. The fund has invested 13.4% of it's portfolio in ILLUMINA INC and 12.7% of portfolio in HARMONY BIOSCIENCES HLDGS IN.
The fund managers got completely rid off ATHIRA PHARMA INC (ATHA), PACIFIC BIOSCIENCES CALIF IN (PACB) and CABALETTA BIO INC (CABA) stocks. They significantly reduced their stock positions in KALVISTA PHARMACEUTICALS INC (KALV). Nan Fung Group Holdings Ltd opened new stock positions in SOLENO THERAPEUTICS INC (SLNO), ELIEM THERAPEUTICS INC (ELYM) and BOLT PROJS HLDGS INC. The fund showed a lot of confidence in some stocks as they added substantially to ZAI LAB LTD (ZLAB), BICYCLE THERAPEUTICS PLC (BCYC) and MADRIGAL PHARMACEUTICALS INC (MDGL).
The top stock holdings of Nan Fung Group Holdings Ltd are ILMN, HRMY, GERN. The fund has invested 13.4% of it's portfolio in ILLUMINA INC and 12.7% of portfolio in HARMONY BIOSCIENCES HLDGS IN.
The fund managers got completely rid off ATHIRA PHARMA INC (ATHA), PACIFIC BIOSCIENCES CALIF IN (PACB) and CABALETTA BIO INC (CABA) stocks. They significantly reduced their stock positions in KALVISTA PHARMACEUTICALS INC (KALV). Nan Fung Group Holdings Ltd opened new stock positions in SOLENO THERAPEUTICS INC (SLNO), ELIEM THERAPEUTICS INC (ELYM) and BOLT PROJS HLDGS INC. The fund showed a lot of confidence in some stocks as they added substantially to ZAI LAB LTD (ZLAB), BICYCLE THERAPEUTICS PLC (BCYC) and MADRIGAL PHARMACEUTICALS INC (MDGL).
Nan Fung Group Holdings Ltd Annual Return Estimates Vs S&P 500
Our best estimate is that Nan Fung Group Holdings Ltd made a return of 8.62% in the last quarter. In trailing 12 months, it's portfolio return was 13.2%.
New Buys
| Ticker | $ Bought |
|---|---|
| soleno therapeutics inc | 3,228,840 |
| eliem therapeutics inc | 2,360,000 |
| bolt projs hldgs inc | 665,801 |
| argenx se | 233,094 |
| ultragenyx pharmaceutical in | 212,201 |
New stocks bought by Nan Fung Group Holdings Ltd
Additions
| Ticker | % Inc. |
|---|---|
| zai lab ltd | 327 |
| bicycle therapeutics plc | 82.57 |
| madrigal pharmaceuticals inc | 71.81 |
| replimune group inc | 40.45 |
| longboard pharmaceuticals in | 11.07 |
Additions to existing portfolio by Nan Fung Group Holdings Ltd
Reductions
| Ticker | % Reduced |
|---|---|
| kalvista pharmaceuticals inc | -29.53 |
Nan Fung Group Holdings Ltd reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| pacific biosciences calif in | -376,049 |
| athira pharma inc | -477,000 |
| fibrogen inc | -55,417 |
| abcellera biologics inc | -150,874 |
| cabaletta bio inc | -352,682 |
| biomea fusion inc | -180,000 |
| roivant sciences ltd | -343,208 |
| kodiak sciences inc | -75,017 |
Nan Fung Group Holdings Ltd got rid off the above stocks
Sector Distribution
Nan Fung Group Holdings Ltd has about 85.9% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 85.9 |
| Others | 14.1 |
Market Cap. Distribution
Nan Fung Group Holdings Ltd has about 27.6% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 32.3 |
| LARGE-CAP | 23.1 |
| MID-CAP | 22.1 |
| UNALLOCATED | 14.1 |
| MEGA-CAP | 4.5 |
| MICRO-CAP | 3.1 |
Stocks belong to which Index?
About 55.2% of the stocks held by Nan Fung Group Holdings Ltd either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 44.8 |
| RUSSELL 2000 | 37.6 |
| S&P 500 | 17.6 |
Nan Fung Group Holdings Ltd Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Nan Fung Group Holdings Ltd
Nan Fung Group Holdings Ltd has 38 stocks in it's portfolio. About 63% of the portfolio is in top 10 stocks. MRUS proved to be the most loss making stock for the portfolio. HRMY was the most profitable stock for Nan Fung Group Holdings Ltd last quarter.
Last Reported on: 13 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABCL | abcellera biologics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ACAD | acadia pharmaceuticals inc | 1.36 | 102,984 | 1,583,890 | unchanged | 0.00 | ||
| ALXO | alx oncology hldgs inc | 0.07 | 41,950 | 76,349 | unchanged | 0.00 | ||
| ATHA | athira pharma inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AVTE | aerovate therapeutics inc | 0.09 | 47,936 | 100,186 | unchanged | 0.00 | ||
| BCYC | bicycle therapeutics plc | 0.62 | 31,585 | 714,769 | added | 82.57 | ||
| BGNE | beigene ltd | 4.45 | 23,022 | 5,168,670 | unchanged | 0.00 | ||
| BMEA | biomea fusion inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BMRN | biomarin pharmaceutical inc | 0.66 | 10,815 | 760,186 | unchanged | 0.00 | ||
| BOLT | bolt biotherapeutics inc | 0.65 | 1,166,950 | 756,185 | unchanged | 0.00 | ||
| CABA | cabaletta bio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| DBVT | dbv technologies s a | 0.11 | 185,475 | 129,833 | unchanged | 0.00 | ||
| ELYM | eliem therapeutics inc | 2.03 | 463,654 | 2,360,000 | new | |||
| EXEL | exelixis inc | 1.44 | 64,200 | 1,665,990 | unchanged | 0.00 | ||
| FGEN | fibrogen inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| GERN | geron corp | 5.37 | 1,373,550 | 6,235,920 | unchanged | 0.00 | ||
| HRMY | harmony biosciences hldgs in | 12.70 | 368,665 | 14,746,600 | unchanged | 0.00 | ||
| ILMN | illumina inc | 13.39 | 119,196 | 15,544,400 | unchanged | 0.00 | ||
| IMCR | immunocore hldgs plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| INCY | incyte corp | 4.22 | 74,022 | 4,892,850 | unchanged | 0.00 | ||